{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:17:02Z","timestamp":1788009422346,"version":"build-2784847793"},"reference-count":120,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004477","name":"Stellenbosch University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004477","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12631-y","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:33:48Z","timestamp":1788003228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["miR-142-3p in cancer: intracellular tumor suppression and extracellular vesicle- mediated microenvironmental signaling"],"prefix":"10.1007","volume":"53","author":[{"given":"Michelle","family":"van der Merwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Towle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy","family":"Myburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathie","family":"Garnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Mart","family":"Engelbrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"issue":"3","key":"12631_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"key":"12631_CR2","doi-asserted-by":"publisher","first-page":"891652","DOI":"10.3389\/fonc.2022.891652","volume":"12","author":"TB Emran","year":"2022","unstructured":"Emran TB et al (2022) Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches. Front Oncol 12:891652","journal-title":"Front Oncol"},{"issue":"5","key":"12631_CR3","first-page":"8172","volume":"15","author":"Y Wang","year":"2018","unstructured":"Wang Y et al (2018) Downregulation of microRNA-142-3p and its tumor suppressor role in gastric cancer. Oncol Lett 15(5):8172\u20138180","journal-title":"Oncol Lett"},{"issue":"3","key":"12631_CR4","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1002\/mc.22935","volume":"58","author":"J Lawson","year":"2019","unstructured":"Lawson J et al (2019) Extracellular vesicle secretion of miR-142-3p from lung adenocarcinoma cells induces tumor promoting changes in the stroma through cell-cell communication. Mol Carcinog 58(3):376\u2013387","journal-title":"Mol Carcinog"},{"issue":"42","key":"12631_CR5","doi-asserted-by":"publisher","first-page":"6529","DOI":"10.1038\/s41388-020-01450-5","volume":"39","author":"B Yang","year":"2020","unstructured":"Yang B et al (2020) High-metastatic cancer cells derived exosomal miR92a-3p promotes epithelial-mesenchymal transition and metastasis of low-metastatic cancer cells by regulating PTEN\/Akt pathway in hepatocellular carcinoma. Oncogene 39(42):6529\u20136543","journal-title":"Oncogene"},{"issue":"11","key":"12631_CR6","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6(11):857\u2013866","journal-title":"Nat Rev Cancer"},{"key":"12631_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13578-015-0047-5","volume":"5","author":"Y Tang","year":"2015","unstructured":"Tang Y et al (2015) MicroRNA-720 promotes in vitro cell migration by targeting Rab35 expression in cervical cancer cells. Cell Biosci 5:56","journal-title":"Cell Biosci"},{"issue":"13","key":"12631_CR8","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1158\/0008-5472.CAN-16-0359","volume":"76","author":"AA Svoronos","year":"2016","unstructured":"Svoronos AA, Engelman DM, Slack FJ (2016) OncomiR or Tumor Suppressor? The Duplicity of MicroRNAs in Cancer. Cancer Res 76(13):3666\u20133670","journal-title":"Cancer Res"},{"issue":"12","key":"12631_CR9","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/s41576-023-00611-y","volume":"24","author":"R Shang","year":"2023","unstructured":"Shang R et al (2023) microRNAs in action: biogenesis, function and regulation. Nat Rev Genet 24(12):816\u2013833","journal-title":"Nat Rev Genet"},{"issue":"3","key":"12631_CR10","first-page":"83","volume":"3","author":"GC Shukla","year":"2011","unstructured":"Shukla GC, Singh J, Barik S (2011) MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. Mol Cell Pharmacol 3(3):83\u201392","journal-title":"Mol Cell Pharmacol"},{"key":"12631_CR11","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O\u2019Brien","year":"2018","unstructured":"O\u2019Brien J et al (2018) Overview of MicroRNA Biogenesis, Mechanisms of Actions, and Circulation. Front Endocrinol (Lausanne) 9:402","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"12631_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.molcel.2004.07.007","volume":"15","author":"G Meister","year":"2004","unstructured":"Meister G et al (2004) Human Argonaute2 Mediates RNA Cleavage Targeted by miRNAs and siRNAs. Mol Cell 15(2):185\u2013197","journal-title":"Mol Cell"},{"issue":"5","key":"12631_CR13","doi-asserted-by":"publisher","first-page":"e10563","DOI":"10.1371\/journal.pone.0010563","volume":"5","author":"J-Y Liao","year":"2010","unstructured":"Liao J-Y et al (2010) Deep Sequencing of Human Nuclear and Cytoplasmic Small RNAs Reveals an Unexpectedly Complex Subcellular Distribution of miRNAs and tRNA 3\u2032 Trailers. PLoS ONE 5(5):e10563","journal-title":"PLoS ONE"},{"issue":"9","key":"12631_CR14","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1261\/rna.1470409","volume":"15","author":"JC Ritland Politz","year":"2009","unstructured":"Ritland Politz JC, Hogan EM, Pederson T (2009) MicroRNAs with a nucleolar location. RNA 15(9):1705\u20131715","journal-title":"RNA"},{"key":"12631_CR15","doi-asserted-by":"crossref","unstructured":"Ren X, Liu G, Zhou J (2025) Nuclear-activating miRNAs: unveiling the intricacies of subcellular miRNA function and regulation in cancer and immunity disease. Cancer Cell Int, 25(1)","DOI":"10.1186\/s12935-025-03760-8"},{"issue":"6","key":"12631_CR16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/ncb1596","volume":"9","author":"H Valadi","year":"2007","unstructured":"Valadi H et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9(6):654\u2013659","journal-title":"Nat Cell Biol"},{"issue":"1","key":"12631_CR17","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12964-023-01102-7","volume":"21","author":"FNA Jahromi","year":"2023","unstructured":"Jahromi FNA, Dowran R, Jafari R (2023) Recent advances in the roles of exosomal microRNAs (exomiRs) in hematologic neoplasms: pathogenesis, diagnosis, and treatment. Cell Commun Signal 21(1):88","journal-title":"Cell Commun Signal"},{"key":"12631_CR18","doi-asserted-by":"crossref","unstructured":"Cammaerts S et al (2015) Genetic variants in microRNA genes: impact on microRNA expression, function, and disease. Front Genet, 6","DOI":"10.3389\/fgene.2015.00186"},{"key":"12631_CR19","doi-asserted-by":"crossref","unstructured":"Semeradtova A et al (2025) Extracellular vesicles in cancer\u00b4s communication: messages we can read and how to answer. Mol Cancer, 24(1)","DOI":"10.1186\/s12943-025-02282-1"},{"key":"12631_CR20","doi-asserted-by":"crossref","unstructured":"Singh B et al (2026) Extracellular vesicle-derived miRNA-182-5p educates macrophages towards an immunosuppressive phenotype in pancreatic cancer. Signal Transduct Target Therapy, 11(1)","DOI":"10.1038\/s41392-025-02559-3"},{"key":"12631_CR21","doi-asserted-by":"crossref","unstructured":"Wei X et al (2023) Multiple myeloma\u2013derived miR-27b\u20103p facilitates tumour progression via promoting tumour cell proliferation and immunosuppressive microenvironment. Clin Translational Med, 13(1)","DOI":"10.1002\/ctm2.1140"},{"issue":"4","key":"12631_CR22","doi-asserted-by":"publisher","first-page":"e1062968","DOI":"10.1080\/2162402X.2015.1062968","volume":"5","author":"G Berchem","year":"2016","unstructured":"Berchem G et al (2016) Hypoxic tumor-derived microvesicles negatively regulate NK cell function by a mechanism involving TGF-\u03b2 and miR23a transfer. OncoImmunology 5(4):e1062968","journal-title":"OncoImmunology"},{"key":"12631_CR23","doi-asserted-by":"publisher","first-page":"110725","DOI":"10.1016\/j.cellsig.2023.110725","volume":"108","author":"B Ye","year":"2023","unstructured":"Ye B et al (2023) Hypoxic tumor-derived exosomal miR-21 induces cancer-associated fibroblast activation to promote head and neck squamous cell carcinoma metastasis. Cell Signal 108:110725","journal-title":"Cell Signal"},{"issue":"1","key":"12631_CR24","doi-asserted-by":"publisher","first-page":"1599680","DOI":"10.1080\/20013078.2019.1599680","volume":"8","author":"LT Vu","year":"2019","unstructured":"Vu LT et al (2019) Tumor-secreted extracellular vesicles promote the activation of cancer\u2010associated fibroblasts via the transfer of microRNA\u2010125b. J Extracell Vesicles 8(1):1599680","journal-title":"J Extracell Vesicles"},{"issue":"6","key":"12631_CR25","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1515\/oncologie-2024-0198","volume":"26","author":"T Zhou","year":"2024","unstructured":"Zhou T, Lu P (2024) Exosomal microRNA-21-5p from gastric cancer cells promotes angiogenesis by targeting LEMD3 in human endothelial cells. Oncologie 26(6):983\u2013992","journal-title":"Oncologie"},{"issue":"7","key":"12631_CR26","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41419-021-03986-0","volume":"12","author":"S Chen","year":"2021","unstructured":"Chen S et al (2021) Retinoblastoma cell-derived exosomes promote angiogenesis of human vesicle endothelial cells through microRNA-92a-3p. Cell Death Dis 12(7):695","journal-title":"Cell Death Dis"},{"issue":"19","key":"12631_CR27","doi-asserted-by":"publisher","first-page":"9323","DOI":"10.3390\/ijms26199323","volume":"26","author":"S Wang","year":"2025","unstructured":"Wang S et al (2025) Exosomal miRNAs: Key Regulators of the Tumor Microenvironment and Cancer Stem Cells. Int J Mol Sci 26(19):9323","journal-title":"Int J Mol Sci"},{"issue":"2","key":"12631_CR28","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s13105-024-01017-y","volume":"80","author":"L Liao","year":"2024","unstructured":"Liao L et al (2024) MicroRNA-126 (MiR-126): key roles in related diseases. J Physiol Biochem 80(2):277\u2013286","journal-title":"J Physiol Biochem"},{"issue":"4","key":"12631_CR29","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1111\/jcmm.16192","volume":"25","author":"L Zhang","year":"2021","unstructured":"Zhang L et al (2021) Exosomes from microRNA-126 overexpressing mesenchymal stem cells promote angiogenesis by targeting the PIK3R2\u2010mediated PI3K\/Akt signalling pathway. J Cell Mol Med 25(4):2148\u20132162","journal-title":"J Cell Mol Med"},{"issue":"11","key":"12631_CR30","first-page":"629","volume":"15","author":"MM Ozarlou","year":"2024","unstructured":"Ozarlou MM et al (2024) MicroRNA-142-3p chemo-sensitizing breast cancer to docetaxel: apoptosis and cell cycle arrest induction, and migration suppression. Vet Res Forum 15(11):629\u2013643","journal-title":"Vet Res Forum"},{"issue":"6","key":"12631_CR31","first-page":"5205","volume":"15","author":"J Gao","year":"2018","unstructured":"Gao J et al (2018) MicroRNA-142-3p inhibits cell proliferation and chemoresistance in ovarian cancer via targeting sirtuin 1. Exp Ther Med 15(6):5205\u20135214","journal-title":"Exp Ther Med"},{"issue":"10","key":"12631_CR32","doi-asserted-by":"publisher","first-page":"8065","DOI":"10.1007\/s13277-015-3483-2","volume":"36","author":"B Deng","year":"2015","unstructured":"Deng B et al (2015) MicroRNA-142-3p inhibits cell proliferation and invasion of cervical cancer cells by targeting FZD7. Tumour Biol 36(10):8065\u20138073","journal-title":"Tumour Biol"},{"issue":"9","key":"12631_CR33","first-page":"4493","volume":"11","author":"C Li","year":"2018","unstructured":"Li C, Feng S, Chen L (2018) MicroRNA-142-3p inhibits proliferation and induces apoptosis by targeting the high-mobility group box 1 via the Wnt\/\u03b2-catenin signaling pathway in glioma. Int J Clin Exp Pathol 11(9):4493\u20134502","journal-title":"Int J Clin Exp Pathol"},{"key":"12631_CR34","doi-asserted-by":"publisher","first-page":"110792","DOI":"10.1016\/j.cellsig.2023.110792","volume":"109","author":"Y Jiang","year":"2023","unstructured":"Jiang Y et al (2023) MicroRNA-142-3P suppresses the progression of papillary thyroid carcinoma by targeting FN1 and inactivating FAK\/ERK\/PI3K signaling. Cell Signal 109:110792","journal-title":"Cell Signal"},{"issue":"6","key":"12631_CR35","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.apsb.2019.11.009","volume":"10","author":"L Liang","year":"2020","unstructured":"Liang L et al (2020) MiR-142-3p enhances chemosensitivity of breast cancer cells and inhibits autophagy by targeting HMGB1. Acta Pharm Sin B 10(6):1036\u20131046","journal-title":"Acta Pharm Sin B"},{"key":"12631_CR36","doi-asserted-by":"publisher","first-page":"110566","DOI":"10.1016\/j.cellsig.2022.110566","volume":"103","author":"Y Shi","year":"2023","unstructured":"Shi Y et al (2023) miR-142-3p improves paclitaxel sensitivity in resistant breast cancer by inhibiting autophagy through the GNB2-AKT-mTOR Pathway. Cell Signal 103:110566","journal-title":"Cell Signal"},{"issue":"1","key":"12631_CR37","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1038\/s41598-025-34163-4","volume":"16","author":"J Wang","year":"2025","unstructured":"Wang J et al (2025) MiR-142-3p targets the CXCL12\/WNT\/\u03b2-catenin pathway to regulate the stemness of breast cancer cells. Sci Rep 16(1):3963","journal-title":"Sci Rep"},{"issue":"9","key":"12631_CR38","doi-asserted-by":"publisher","first-page":"15252","DOI":"10.18632\/oncotarget.14862","volume":"8","author":"CT Dickman","year":"2017","unstructured":"Dickman CT et al (2017) Selective extracellular vesicle exclusion of miR-142-3p by oral cancer cells promotes both internal and extracellular malignant phenotypes. Oncotarget 8(9):15252\u201315266","journal-title":"Oncotarget"},{"issue":"48","key":"12631_CR39","doi-asserted-by":"publisher","first-page":"83913","DOI":"10.18632\/oncotarget.19996","volume":"8","author":"J Lawson","year":"2017","unstructured":"Lawson J et al (2017) Selective secretion of microRNAs from lung cancer cells via extracellular vesicles promotes CAMK1D-mediated tube formation in endothelial cells. Oncotarget 8(48):83913\u201383924","journal-title":"Oncotarget"},{"key":"12631_CR40","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.omtn.2023.05.023","volume":"33","author":"X Gu","year":"2023","unstructured":"Gu X et al (2023) MicroRNA-142a-3p regulates neurogenic skeletal muscle atrophy by targeting Mef2a. Mol Ther Nucleic Acids 33:191\u2013204","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6","key":"12631_CR41","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1016\/j.immuni.2013.06.004","volume":"38","author":"N Sonda","year":"2013","unstructured":"Sonda N et al (2013) miR-142-3p prevents macrophage differentiation during cancer-induced myelopoiesis. Immunity 38(6):1236\u20131249","journal-title":"Immunity"},{"issue":"1","key":"12631_CR42","doi-asserted-by":"publisher","first-page":"32925","DOI":"10.1038\/srep32925","volume":"6","author":"AR Naqvi","year":"2016","unstructured":"Naqvi AR et al (2016) miR-24, miR-30b and miR-142-3p interfere with antigen processing and presentation by primary macrophages and dendritic cells. Sci Rep 6(1):32925","journal-title":"Sci Rep"},{"issue":"5","key":"12631_CR43","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/j.rbmo.2015.01.002","volume":"30","author":"CS K\u00e4stingsch\u00e4fer","year":"2015","unstructured":"K\u00e4stingsch\u00e4fer CS et al (2015) miR-142-3p is a novel regulator of cell viability and proinflammatory signalling in endometrial stroma cells. Reprod Biomed Online 30(5):553\u2013556","journal-title":"Reprod Biomed Online"},{"key":"12631_CR44","doi-asserted-by":"crossref","unstructured":"Tong F et al (2020) Comprehensive profiling of extracellular RNA in HPV-induced cancers using an improved pipeline for small RNA-seq analysis. Sci Rep, 10(1)","DOI":"10.1038\/s41598-020-76623-z"},{"key":"12631_CR45","doi-asserted-by":"crossref","unstructured":"Zareifar P et al (2024) miR-142\u20103p\/5p role in cancer: From epigenetic regulation to immunomodulation. Cell Biochem Funct, 42(2)","DOI":"10.1002\/cbf.3931"},{"key":"12631_CR46","doi-asserted-by":"publisher","first-page":"149467","DOI":"10.1016\/j.gene.2025.149467","volume":"957","author":"M van der Merwe","year":"2025","unstructured":"van der Merwe M et al (2025) Unravelling the role of extracellular vesicles in cervical cancer: Mechanisms of progression, resistance, and emerging therapeutic strategies. Gene 957:149467","journal-title":"Gene"},{"key":"12631_CR47","doi-asserted-by":"crossref","unstructured":"N., C.G.A.R., Comprehensive molecular profiling of lung adenocarcinoma. Nature, (2014) 511(7511): p. 543\u2013550","DOI":"10.1038\/nature13385"},{"issue":"4","key":"12631_CR48","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s13577-019-00258-0","volume":"32","author":"C Jin","year":"2019","unstructured":"Jin C et al (2019) MiR-142-3p suppresses the proliferation, migration and invasion through inhibition of NR2F6 in lung adenocarcinoma. Hum Cell 32(4):437\u2013446","journal-title":"Hum Cell"},{"issue":"9","key":"12631_CR49","doi-asserted-by":"publisher","first-page":"5234","DOI":"10.1039\/C8RA09914F","volume":"9","author":"X Song","year":"2019","unstructured":"Song X et al (2019) miR-124 and miR-142 enhance cisplatin sensitivity of non-small cell lung cancer cells through repressing autophagy via directly targeting SIRT1. RSC Adv 9(9):5234\u20135243","journal-title":"RSC Adv"},{"issue":"6","key":"12631_CR50","doi-asserted-by":"publisher","first-page":"9816","DOI":"10.1002\/jcp.27670","volume":"234","author":"B Mansoori","year":"2019","unstructured":"Mansoori B et al (2019) miR-142-3p as tumor suppressor miRNA in the regulation of tumorigenicity, invasion and migration of human breast cancer by targeting Bach-1 expression. J Cell Physiol 234(6):9816\u20139825","journal-title":"J Cell Physiol"},{"key":"12631_CR51","doi-asserted-by":"crossref","unstructured":"Xie N et al (2021) MicroRNA\u2013142\u20133p suppresses cell proliferation, invasion and epithelial\u2013to\u2013mesenchymal transition via RAC1\u2013ERK1\/2 signaling in colorectal cancer. Mol Med Rep, 24(2)","DOI":"10.3892\/mmr.2021.12207"},{"key":"12631_CR52","doi-asserted-by":"crossref","unstructured":"Fan A et al (2024) HMGB1\/RAGE axis in tumor development: unraveling its significance. Front Oncol, 14","DOI":"10.3389\/fonc.2024.1336191"},{"issue":"3","key":"12631_CR53","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3892\/etm.2021.9644","volume":"21","author":"H Dong","year":"2021","unstructured":"Dong H, Song J (2021) miR-142-3p reduces the viability of human cervical cancer cells by negatively regulating the cytoplasmic localization of HMGB1. Exp Ther Med 21(3):212","journal-title":"Exp Ther Med"},{"key":"12631_CR54","doi-asserted-by":"publisher","first-page":"120268","DOI":"10.1016\/j.lfs.2021.120268","volume":"291","author":"P Sharma","year":"2022","unstructured":"Sharma P et al (2022) miR-142-3p simultaneously targets HMGA1, HMGA2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells. Life Sci 291:120268","journal-title":"Life Sci"},{"key":"12631_CR55","doi-asserted-by":"crossref","unstructured":"Wei Y et al (2025) Exosomal miR-142\u20103p from M1polarized macrophages suppresses cell growth and immune escape in glioblastoma through regulating HMGB1\u2010mediated PD\u20101\/PDL1 checkpoint. J Neurochem, 169(1)","DOI":"10.1111\/jnc.16224"},{"key":"12631_CR56","doi-asserted-by":"publisher","first-page":"718731","DOI":"10.3389\/fonc.2021.718731","volume":"11","author":"Z Chen","year":"2021","unstructured":"Chen Z et al (2021) Downregulation of miR-142a Contributes to the Enhanced Anti-Apoptotic Ability of Murine Chronic Myelogenous Leukemia Cells. Front Oncol 11:718731","journal-title":"Front Oncol"},{"issue":"1","key":"12631_CR57","doi-asserted-by":"publisher","first-page":"20794","DOI":"10.1038\/s41598-024-71405-3","volume":"14","author":"H Yuan","year":"2024","unstructured":"Yuan H et al (2024) Downregulation of CIAPIN1 regulates the proliferation, migration and glycolysis of breast cancer cells via inhibition of STAT3 pathway. Sci Rep 14(1):20794","journal-title":"Sci Rep"},{"key":"12631_CR58","doi-asserted-by":"crossref","unstructured":"Godin L et al (2020) A Novel Approach for Quantifying Cancer Cells Showing Hybrid Epithelial\/Mesenchymal States in Large Series of Tissue Samples: Towards a New Prognostic Marker. Cancers (Basel), 12(4)","DOI":"10.3390\/cancers12040906"},{"issue":"7","key":"12631_CR59","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s00204-021-03063-7","volume":"95","author":"J De Las Rivas","year":"2021","unstructured":"De Las Rivas J et al (2021) Cancer drug resistance induced by EMT: novel therapeutic strategies. Arch Toxicol 95(7):2279\u20132297","journal-title":"Arch Toxicol"},{"issue":"1","key":"12631_CR60","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1186\/s12964-024-01957-4","volume":"22","author":"M Liaghat","year":"2024","unstructured":"Liaghat M et al (2024) The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors. Cell Commun Signal 22(1):575","journal-title":"Cell Commun Signal"},{"issue":"7015","key":"12631_CR61","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nature03128","volume":"432","author":"SK Singh","year":"2004","unstructured":"Singh SK et al (2004) Identification of human brain tumour initiating cells. Nature 432(7015):396\u2013401","journal-title":"Nature"},{"issue":"2","key":"12631_CR62","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1038\/nrm1835","volume":"7","author":"JP Thiery","year":"2006","unstructured":"Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7(2):131\u2013142","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"12631_CR63","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1172\/JCI39104","volume":"119","author":"R Kalluri","year":"2009","unstructured":"Kalluri R, Weinberg RA (2009) The basics of epithelial-mesenchymal transition. J Clin Invest 119(6):1420\u20131428","journal-title":"J Clin Invest"},{"issue":"4","key":"12631_CR64","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1159\/000467896","volume":"41","author":"Y Chen","year":"2017","unstructured":"Chen Y et al (2017) MiR-142-3p Overexpression Increases Chemo-Sensitivity of NSCLC by Inhibiting HMGB1-Mediated Autophagy. Cell Physiol Biochem 41(4):1370\u20131382","journal-title":"Cell Physiol Biochem"},{"key":"12631_CR65","doi-asserted-by":"crossref","unstructured":"Liang G et al (2020) Engineered exosomes for targeted co-delivery of miR-21 inhibitor and chemotherapeutics to reverse drug resistance in colon cancer. J Nanobiotechnol, 18(1)","DOI":"10.1186\/s12951-019-0563-2"},{"key":"12631_CR66","doi-asserted-by":"crossref","unstructured":"Burdiel M et al (2026) Unveiling miR-451a and miR\u2010142\u20103p as prognostic markers in non\u2010small cell lung cancer via small extracellular vesicle liquid biopsy. Clin Translational Med, 16(3)","DOI":"10.1002\/ctm2.70634"},{"key":"12631_CR67","doi-asserted-by":"publisher","first-page":"365","DOI":"10.2147\/OTT.S185876","volume":"12","author":"T Xu","year":"2019","unstructured":"Xu T, Jiang L, Wang Z (2019) The progression of HMGB1-induced autophagy in cancer biology. Onco Targets Ther 12:365\u2013377","journal-title":"Onco Targets Ther"},{"key":"12631_CR68","doi-asserted-by":"crossref","unstructured":"Bahar E et al (2022) Chemotherapy Resistance: Role of Mitochondrial and Autophagic Components. Cancers (Basel), 14(6)","DOI":"10.3390\/cancers14061462"},{"issue":"11","key":"12631_CR69","doi-asserted-by":"publisher","first-page":"8585","DOI":"10.1007\/s13277-015-3617-6","volume":"36","author":"R Zhang","year":"2015","unstructured":"Zhang R et al (2015) Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis. Tumour Biol 36(11):8585\u20138592","journal-title":"Tumour Biol"},{"issue":"9","key":"12631_CR70","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0302-7","volume":"51","author":"IH Lee","year":"2019","unstructured":"Lee IH (2019) Mechanisms and disease implications of sirtuin-mediated autophagic regulation. Exp Mol Med 51(9):1\u201311","journal-title":"Exp Mol Med"},{"key":"12631_CR71","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1146\/annurev-cellbio-101512-122326","volume":"30","author":"M Colombo","year":"2014","unstructured":"Colombo M, Raposo G, Th\u00e9ry C (2014) Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles. Annu Rev Cell Dev Biol 30:255\u2013289","journal-title":"Annu Rev Cell Dev Biol"},{"key":"12631_CR72","doi-asserted-by":"crossref","unstructured":"Hamzah RN et al (2021) Exosome Traceability and Cell Source Dependence on Composition and Cell-Cell Cross Talk. Int J Mol Sci, 22(10)","DOI":"10.3390\/ijms22105346"},{"issue":"1","key":"12631_CR73","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.neo.2020.11.011","volume":"23","author":"MP Bebelman","year":"2021","unstructured":"Bebelman MP et al (2021) The forces driving cancer extracellular vesicle secretion. Neoplasia 23(1):149\u2013157","journal-title":"Neoplasia"},{"issue":"1","key":"12631_CR74","doi-asserted-by":"publisher","first-page":"e1376153","DOI":"10.1080\/2162402X.2017.1376153","volume":"7","author":"L K\u00f6nig","year":"2017","unstructured":"K\u00f6nig L et al (2017) Elevated levels of extracellular vesicles are associated with therapy failure and disease progression in breast cancer patients undergoing neoadjuvant chemotherapy. Oncoimmunology 7(1):e1376153","journal-title":"Oncoimmunology"},{"issue":"1","key":"12631_CR75","doi-asserted-by":"publisher","first-page":"101175","DOI":"10.1016\/j.gendis.2023.101175","volume":"12","author":"M Huang","year":"2025","unstructured":"Huang M et al (2025) Known and unknown: Exosome secretion in tumor microenvironment needs more exploration. Genes Dis 12(1):101175","journal-title":"Genes Dis"},{"issue":"1","key":"12631_CR76","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/mc.23129","volume":"59","author":"TC Peak","year":"2020","unstructured":"Peak TC et al (2020) Syntaxin 6-mediated exosome secretion regulates enzalutamide resistance in prostate cancer. Mol Carcinog 59(1):62\u201372","journal-title":"Mol Carcinog"},{"issue":"10","key":"12631_CR77","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1158\/1535-7163.MCT-05-0102","volume":"4","author":"R Safaei","year":"2005","unstructured":"Safaei R et al (2005) Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells. Mol Cancer Ther 4(10):1595\u20131604","journal-title":"Mol Cancer Ther"},{"key":"12631_CR78","doi-asserted-by":"publisher","first-page":"100833","DOI":"10.1016\/j.drup.2022.100833","volume":"62","author":"CPR Xavier","year":"2022","unstructured":"Xavier CPR et al (2022) The role of extracellular vesicles in the transfer of drug resistance competences to cancer cells. Drug Resist Updat 62:100833","journal-title":"Drug Resist Updat"},{"issue":"3","key":"12631_CR79","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.celrep.2016.09.031","volume":"17","author":"L Santangelo","year":"2016","unstructured":"Santangelo L et al (2016) The RNA-Binding Protein SYNCRIP Is a Component of the Hepatocyte Exosomal Machinery Controlling MicroRNA Sorting. Cell Rep 17(3):799\u2013808","journal-title":"Cell Rep"},{"issue":"6","key":"12631_CR80","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1007\/s13402-025-01108-y","volume":"48","author":"X Ji","year":"2025","unstructured":"Ji X et al (2025) Fibroblasts in the tumor microenvironment: heterogeneity and dynamic interactions in tumor progression revealed by spatial transcriptomics. Cell Oncol 48(6):1615\u20131629","journal-title":"Cell Oncol"},{"issue":"3","key":"12631_CR81","doi-asserted-by":"publisher","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","volume":"2","author":"N Nishida","year":"2006","unstructured":"Nishida N et al (2006) Angiogenesis in cancer. Vasc Health Risk Manag 2(3):213\u2013219","journal-title":"Vasc Health Risk Manag"},{"key":"12631_CR82","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1159\/000088478","volume":"69 3","author":"P Carmeliet","year":"2005","unstructured":"Carmeliet P (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69 3:4\u201310","journal-title":"Oncology"},{"key":"12631_CR83","doi-asserted-by":"crossref","unstructured":"Ateeq M et al (2024) Extracellular Vesicles\u2019 Role in Angiogenesis and Altering Angiogenic Signaling. Med Sci (Basel), 12(1)","DOI":"10.3390\/medsci12010004"},{"key":"12631_CR84","doi-asserted-by":"publisher","first-page":"131419","DOI":"10.1016\/j.cej.2021.131419","volume":"427","author":"L Chen","year":"2022","unstructured":"Chen L et al (2022) Regulatory T cell-exosomal miR-142-3p promotes angiogenesis and osteogenesis via TGFBR1\/SMAD2 inhibition to accelerate fracture repair. Chem Eng J 427:131419","journal-title":"Chem Eng J"},{"issue":"9","key":"12631_CR85","doi-asserted-by":"publisher","first-page":"12359","DOI":"10.18632\/aging.203035","volume":"13","author":"Q Roblain","year":"2021","unstructured":"Roblain Q et al (2021) Intravitreal injection of anti-miRs against miR-142-3p reduces angiogenesis and microglia activation in a mouse model of laser-induced choroidal neovascularization. Aging 13(9):12359\u201312377","journal-title":"Aging"},{"key":"12631_CR86","doi-asserted-by":"crossref","unstructured":"Shi X et al (2020) Transforming Growth Factor-\u03b2 Signaling in Fibrotic Diseases and Cancer-Associated Fibroblasts. Biomolecules, 10(12)","DOI":"10.3390\/biom10121666"},{"issue":"4","key":"12631_CR87","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.3390\/ph3041241","volume":"3","author":"M Rusnati","year":"2010","unstructured":"Rusnati M et al (2010) Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action. Pharmaceuticals (Basel) 3(4):1241\u20131278","journal-title":"Pharmaceuticals (Basel)"},{"issue":"4","key":"12631_CR88","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s10456-024-09942-8","volume":"27","author":"LE Wazan","year":"2024","unstructured":"Wazan LE, Widhibrata A, Liu GS (2024) Soluble FLT-1 in angiogenesis: pathophysiological roles and therapeutic implications. Angiogenesis 27(4):641\u2013661","journal-title":"Angiogenesis"},{"issue":"5","key":"12631_CR89","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.21037\/tcr-22-96","volume":"11","author":"Z Hu","year":"2022","unstructured":"Hu Z et al (2022) Mechanism of HBV-positive liver cancer cell exosomal miR-142-3p by inducing ferroptosis of M1 macrophages to promote liver cancer progression. Transl Cancer Res 11(5):1173\u20131187","journal-title":"Transl Cancer Res"},{"issue":"1","key":"12631_CR90","doi-asserted-by":"publisher","first-page":"101198","DOI":"10.3748\/wjg.v31.i1.101198","volume":"31","author":"XH Yu","year":"2025","unstructured":"Yu XH et al (2025) Loss-of-function mutations of microRNA-142-3p promote ASH1L expression to induce immune evasion and hepatocellular carcinoma progression. World J Gastroenterol 31(1):101198","journal-title":"World J Gastroenterol"},{"key":"12631_CR91","doi-asserted-by":"crossref","unstructured":"Tan Y et al (2026) Cancer cachexia: molecular basis and therapeutic advances. Signal Transduct Target Therapy, 11(1)","DOI":"10.1038\/s41392-025-02331-7"},{"issue":"4","key":"12631_CR92","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1038\/s41571-023-00734-5","volume":"20","author":"JM Argil\u00e9s","year":"2023","unstructured":"Argil\u00e9s JM et al (2023) Cancer-associated cachexia - understanding the tumour macroenvironment and microenvironment to improve management. Nat Rev Clin Oncol 20(4):250\u2013264","journal-title":"Nat Rev Clin Oncol"},{"key":"12631_CR93","doi-asserted-by":"publisher","first-page":"5597","DOI":"10.2147\/CMAR.S261585","volume":"12","author":"J Ni","year":"2020","unstructured":"Ni J, Zhang L (2020) Cancer Cachexia: Definition, Staging, and Emerging Treatments. Cancer Manage Res 12:5597\u20135605","journal-title":"Cancer Manage Res"},{"key":"12631_CR94","doi-asserted-by":"crossref","unstructured":"Yabe M et al (2025) Effect of Cancer Cachexia on the Efficacy and Treatment Delivery of Chemotherapy in Older Patients With Advanced Small Cell Lung Cancer. Thorac Cancer, 16(12)","DOI":"10.1111\/1759-7714.70104"},{"issue":"1","key":"12631_CR95","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s13410-011-0057-8","volume":"32","author":"PG Raman","year":"2012","unstructured":"Raman PG, Bootwala AZ, Petiwala TA (2012) Cancer cachexia as a model for treatment of obesity. Int J Diabetes Developing Ctries 32(1):61\u201361","journal-title":"Int J Diabetes Developing Ctries"},{"issue":"6","key":"12631_CR96","doi-asserted-by":"publisher","first-page":"189208","DOI":"10.1016\/j.bbcan.2024.189208","volume":"1879","author":"L Li","year":"2024","unstructured":"Li L, Ling ZQ (2024) Mechanisms of cancer cachexia and targeted therapeutic strategies. Biochim Biophys Acta Rev Cancer 1879(6):189208","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"11","key":"12631_CR97","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1038\/nrc3829","volume":"14","author":"JM Argil\u00e9s","year":"2014","unstructured":"Argil\u00e9s JM et al (2014) Cancer cachexia: understanding the molecular basis. Nat Rev Cancer 14(11):754\u2013762","journal-title":"Nat Rev Cancer"},{"issue":"6","key":"12631_CR98","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1038\/s44319-024-00144-3","volume":"25","author":"YY Kwon","year":"2024","unstructured":"Kwon YY, Hui S (2024) IL-6 promotes tumor growth through immune evasion but is dispensable for cachexia. EMBO Rep 25(6):2592\u20132609","journal-title":"EMBO Rep"},{"key":"12631_CR99","doi-asserted-by":"crossref","unstructured":"Madeddu C et al (2023) Effect of Cancer-Related Cachexia and Associated Changes in Nutritional Status, Inflammatory Status, and Muscle Mass on Immunotherapy Efficacy and Survival in Patients with Advanced Non-Small Cell Lung Cancer. Cancers (Basel), 15(4)","DOI":"10.3390\/cancers15041076"},{"key":"12631_CR100","doi-asserted-by":"crossref","unstructured":"Wang Y, Ding S (2024) Extracellular vesicles in cancer cachexia: deciphering pathogenic roles and exploring therapeutic horizons. J Translational Med, 22(1)","DOI":"10.1186\/s12967-024-05266-9"},{"key":"12631_CR101","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3389\/fnmol.2018.00069","volume":"11","author":"J Weng","year":"2018","unstructured":"Weng J et al (2018) The Whole Transcriptome Involved in Denervated Muscle Atrophy Following Peripheral Nerve Injury. Front Mol Neurosci 11:69","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"12631_CR102","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1152\/physiolgenomics.00134.2017","volume":"50","author":"AA Fiorillo","year":"2018","unstructured":"Fiorillo AA et al (2018) Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone. Physiol Genomics 50(9):735\u2013745","journal-title":"Physiol Genomics"},{"issue":"7","key":"12631_CR103","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/art.41215","volume":"72","author":"TB Kinder","year":"2020","unstructured":"Kinder TB et al (2020) Muscle Weakness in Myositis: MicroRNA-Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies. Arthritis Rheumatol 72(7):1170\u20131183","journal-title":"Arthritis Rheumatol"},{"issue":"9","key":"12631_CR104","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/s10038-021-00938-6","volume":"66","author":"J Inoue","year":"2021","unstructured":"Inoue J, Inazawa J (2021) Cancer-associated miRNAs and their therapeutic potential. J Hum Genet 66(9):937\u2013945","journal-title":"J Hum Genet"},{"key":"12631_CR105","doi-asserted-by":"crossref","unstructured":"Martino MTD, Tagliaferri P, Tassone P (2025) MicroRNA in cancer therapy: breakthroughs and challenges in early clinical applications. J Experimental Clin Cancer Res, 44(1)","DOI":"10.1186\/s13046-025-03391-x"},{"issue":"4","key":"12631_CR106","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/s41417-025-00885-w","volume":"32","author":"G Reid","year":"2025","unstructured":"Reid G et al (2025) Therapeutic potential of synthetic microRNA mimics based on the miR-15\/107 consensus sequence. Cancer Gene Ther 32(4):486\u2013496","journal-title":"Cancer Gene Ther"},{"issue":"11","key":"12631_CR107","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/s41416-020-0802-1","volume":"122","author":"DS Hong","year":"2020","unstructured":"Hong DS et al (2020) Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours. Br J Cancer 122(11):1630\u20131637","journal-title":"Br J Cancer"},{"issue":"10","key":"12631_CR108","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","volume":"18","author":"N van Zandwijk","year":"2017","unstructured":"van Zandwijk N et al (2017) Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study. Lancet Oncol 18(10):1386\u20131396","journal-title":"Lancet Oncol"},{"key":"12631_CR109","doi-asserted-by":"crossref","unstructured":"Wang Z et al (2025) MiRNA-based drugs: challenges and delivery strategies. Appl Microbiol Biotechnol, 109(1)","DOI":"10.1007\/s00253-025-13620-0"},{"issue":"1","key":"12631_CR110","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/1478-811X-11-88","volume":"11","author":"TA Shtam","year":"2013","unstructured":"Shtam TA et al (2013) Exosomes are natural carriers of exogenous siRNA to human cells in vitro. Cell Communication Signal 11(1):88","journal-title":"Cell Communication Signal"},{"key":"12631_CR111","doi-asserted-by":"crossref","unstructured":"Shojaei S et al (2023) Mesenchymal stem cell-derived exosomes enriched with miR-218 reduce the epithelial\u2013mesenchymal transition and angiogenesis in triple-negative breast cancer cells. Eur J Med Res, 28(1)","DOI":"10.1186\/s40001-023-01463-2"},{"key":"12631_CR112","doi-asserted-by":"publisher","first-page":"119800","DOI":"10.1016\/j.lfs.2021.119800","volume":"282","author":"M Moradi-Chaleshtori","year":"2021","unstructured":"Moradi-Chaleshtori M et al (2021) Transfer of miRNA in tumor-derived exosomes suppresses breast tumor cell invasion and migration by inducing M1 polarization in macrophages. Life Sci 282:119800","journal-title":"Life Sci"},{"issue":"3","key":"12631_CR113","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s12015-020-10089-4","volume":"17","author":"S Shojaei","year":"2021","unstructured":"Shojaei S et al (2021) Delivery of miR-381-3p Mimic by Mesenchymal Stem Cell-Derived Exosomes Inhibits Triple Negative Breast Cancer Aggressiveness; an In Vitro Study. Stem Cell Reviews Rep 17(3):1027\u20131038","journal-title":"Stem Cell Reviews Rep"},{"issue":"2","key":"12631_CR114","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41419-021-03456-7","volume":"12","author":"L Luo","year":"2021","unstructured":"Luo L et al (2021) BCAT1 decreases the sensitivity of cancer cells to cisplatin by regulating mTOR-mediated autophagy via branched-chain amino acid metabolism. Cell Death Dis 12(2):169","journal-title":"Cell Death Dis"},{"issue":"8","key":"12631_CR115","doi-asserted-by":"publisher","first-page":"110391","DOI":"10.1016\/j.isci.2024.110391","volume":"27","author":"H Sultana","year":"2024","unstructured":"Sultana H, Ahmed W, Neelakanta G (2024) GW4869 inhibitor affects vector competence and tick-borne flavivirus acquisition and transmission by blocking exosome secretion. iScience 27(8):110391","journal-title":"iScience"},{"key":"12631_CR116","doi-asserted-by":"crossref","unstructured":"Irep N et al (2024) Exosome inhibition improves response to first-line therapy in small cell lung cancer. J Cell Mol Med, 28(4)","DOI":"10.1111\/jcmm.18138"},{"issue":"1","key":"12631_CR117","doi-asserted-by":"publisher","first-page":"24641","DOI":"10.3402\/jev.v3.24641","volume":"3","author":"LA Mulcahy","year":"2014","unstructured":"Mulcahy LA, Pink RC, Carter DRF (2014) Routes and mechanisms of extracellular vesicle uptake. J Extracell Vesicles 3(1):24641","journal-title":"J Extracell Vesicles"},{"key":"12631_CR118","doi-asserted-by":"publisher","first-page":"117019","DOI":"10.1016\/j.bcp.2025.117019","volume":"239","author":"SG Gabaran","year":"2025","unstructured":"Gabaran SG et al (2025) An updated review on the inhibition of exosome biogenesis, release, and uptake: a potential anticancer approach. Biochem Pharmacol 239:117019","journal-title":"Biochem Pharmacol"},{"key":"12631_CR119","doi-asserted-by":"crossref","unstructured":"Datta A et al (2018) High-throughput screening identified selective inhibitors of exosome biogenesis and secretion: A drug repurposing strategy for advanced cancer. Sci Rep, 8(1)","DOI":"10.1038\/s41598-018-26411-7"},{"issue":"2","key":"12631_CR120","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/cas.15225","volume":"113","author":"E Sasabe","year":"2022","unstructured":"Sasabe E et al (2022) Epidermal growth factor\/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis. Cancer Sci 113(2):609\u2013621","journal-title":"Cancer Sci"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12631-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12631-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12631-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:03:08Z","timestamp":1788008588000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12631-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":120,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12631"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12631-y","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"10 July 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Ethical Statement","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1501"}}